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Sensing intracellular pathogens is a process mediated by innate immune cells that is cru-
cial for the induction of inflammatory processes and effective adaptive immune responses
against pathogenic microbes. NOD-like receptors (NLRs) comprise a family of intracel-
lular pattern recognition receptors that are important for the recognition of damage and
microbial-associated molecular patterns. NOD1 and NOD2 are specialized NLRs that partic-
ipate in the recognition of a subset of pathogenic microorganisms that are able to invade
and multiply intracellularly. Once activated, these molecules trigger intracellular signal-
ing pathways that lead to the activation of transcriptional responses culminating in the
expression of a subset of inflammatory genes. In this review, we will focus on the role
of NOD1 and NOD2 in the recognition and response to intracellular pathogens, including
Gram-positive and Gram-negative bacteria, and on their ability to signal in response to
non-peptidoglycan-containing pathogens, such as viruses and protozoan parasites.
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INTRODUCTION
The immune system is able to recognize a large variety of microor-
ganisms and their molecules through different receptors expressed
by innate immune cells, such as macrophages, neutrophils, NK
cells, and dendritic cells. The initial recognition of pathogenic
microorganisms is critical for the generation of an appropri-
ate acquired immune response. This process occurs through the
interaction of microbial- or damage-associated molecular patterns
(MAMPs or DAMPs, respectively) with the specific pattern recog-
nition receptors (PRRs) present on the host cell surface or in the
cytosolic compartment. Among the PRRs, the Toll-like receptors
(TLRs), NOD-like receptors (NLRs), RIG-like helicases (RLRs),
and AIM2-like receptors (ALRs) have been extensively investigated
and play important roles as the major PRRs, forming the first line
of defense against infectious agents (reviewed in Kawai and Akira,
2009; Schroder and Tschopp, 2010; Bonardi et al., 2012).
The TLRs are a group of transmembrane receptors that are able
to recognize a large variety of MAMPs from different pathogenic
microorganisms and induce the activation of the innate immune
system (Janeway and Medzhitov, 2002). In humans, 10 functional
TLRs have been identified, and a large amount of data demon-
strates that TLRs may also work as sensors for self/endogenous
molecules or“alarmins”that contribute to inflammatory processes
and may be important for the maintenance of host homeostasis
(reviewed in Kawai and Akira, 2009).
About 15 years ago, another family of PRRs was identified in
humans. Proteins from this family contain a nucleotide-binding
and oligomerization domain (NOD) and were named NLRs (Ino-
hara et al., 1999, 2000; Girardin et al., 2001; Hoffman et al., 2001;
Albrecht et al., 2003). The NLR family includes 22 members iden-
tified in humans and more than 30 in mice (Ting et al., 2008;
Schroder and Tschopp, 2010).
The most studied NLRs belong to the NLRC and NLRP sub-
groups. The former is composed of receptors containing a Pyrin
domain in the amino-terminal region of the protein; these recep-
tors are usually involved in the activation of caspase-1 and the
assembly of the inflammasome, a molecular platform that has
been reviewed elsewhere (Kanneganti et al., 2007; Schroder and
Tschopp, 2010; Shaw et al., 2010). The NLRC subgroup is com-
posed of receptors containing a Card domain in the amino-
terminal region and includes members such as NOD1 and NOD2
that play important roles in pathogen recognition and the acti-
vation of immune responses. NOD1 and NOD2 are encoded by
the card4 and card15 genes, respectively, and are involved with the
recognition of peptidoglycan moieties from Gram-positive and
Gram-negative bacteria (Inohara et al., 2001; Chamaillard et al.,
2003; Girardin et al., 2003a,b,c). Nevertheless, increasing numbers
of recent reports suggest that NOD1 and NOD2 have important
functions in non-bacterial infections. Whether NOD1 and NOD2
sense other structures and microbes or participate only as signaling
partners is still unclear.
In this review, we will focus on functional aspects of the NOD1
and NOD2 proteins and discuss recent findings related to their
roles in microbial recognition and the induction of inflammatory
responses that lead to the restriction of infections with bacterial
and non-bacterial pathogenic microbes.
STRUCTURE AND SIGNALING OF NOD1 AND NOD2
Structurally, NLRs are multi-domain proteins that contain an
N-terminal Caspase Recruitment Domain (CARD) that asso-
ciates with downstream signaling molecules, a centrally located
nucleotide-binding oligomerization domain (NBD or NACHT),
and a C-terminal leucine-rich repeat domain (LRR) or sensor
domain (Proell et al., 2008; Schroder and Tschopp, 2010). NLRs
vary in their N-terminal effector domains (PYD, CARD, BIR,
and unclassified). Based on the domains present in this region,
the NLRs are classified in two subgroups: NLRCs (CARD), and
NLRPs (PYRIN). The NLR members NOD1 and NOD2 belong
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to the NLRC subgroup as they contain an amino-terminal CARD
domain and share the two common domains (NBD and LRR).
NOD1 contains a single CARD domain, whereas NOD2 has two
(Ogura et al., 2001). The carboxy terminal LRR domain is pre-
dicted to mediate protein–protein interactions and function as
the regulatory domain. NOD1 and NOD2 contain multiple LRRs,
a motif that has been linked to resistance to infection and is found
in TLRs and plant R proteins (reviewed by Murray, 2005).
The idea that NOD1 and NOD2 function as intracellular recep-
tors for bacterial peptidoglycan fragments emerged from studies
using the over-expression of NOD1 and NOD2 and an NF-κB
reporter in HEK293T cells (Inohara et al., 2001; Chamaillard et al.,
2003; Girardin et al., 2003a,b,c). Further studies demonstrated that
NOD1 activity was triggered by d-glutamyl-meso-diaminopimelic
acid (DAP), which is found in Gram-negative and a few Gram-
positive bacteria, including Listeria and Bacillus (Chamaillard
et al., 2003; Hasegawa et al., 2006). In contrast, NOD2 acti-
vation was triggered by muramyl dipeptide (MDP), a peptido-
glycan motif widely distributed among both Gram-positive and
Gram-negative bacteria (Girardin et al., 2003b,c).
Until recently, the direct binding of NOD1 and NOD2 to their
respective ligands, DAP and MDP, had not been demonstrated
in a physiological milieu. However, the direct binding of MDP
to NOD2 has recently been reported, suggesting the first bio-
chemical evidence for a direct interaction between NOD2 and
MDP (Grimes et al., 2012). In addition to NOD2 activation, dif-
ferent groups have reported that MDP is involved in the activation
of other NLRs, including NLRP3 (Martinon et al., 2004; Pan
et al., 2007) and NLRP1 (Hsu et al., 2008). The putative acti-
vation of NLRP3 and NLRP1 by MDP leads to the production
and secretion of IL-1β, an important proinflammatory cytokine
(Martinon et al., 2004; Hsu et al., 2008). Although it has been
demonstrated that MDP triggers the production of cytokines,
chemokines, nitric oxide (NO), and reactive oxygen species, several
studies have shown that MDP alone is only weakly immunostimu-
latory (Parant et al., 1995; Wolfert et al., 2002; Pauleau and Murray,
2003; Kobayashi et al., 2005; Uehori et al., 2005; Kinsner et al.,
2006; Moreira et al., 2008a). MDP has been shown to act synergis-
tically with TLRs; the addition of MDP in combination with TLR
agonists, such as lipoteicoic acid (LTA), LPS, and peptidoglycan,
triggers a robust inflammatory response, including the release of
proinflammatory cytokines such as IL-1β and IL-6 (Wolfert et al.,
2002; Kim et al., 2007; Natsuka et al., 2008). As expected, the syn-
ergistic effect of MDP with TLR agonists is dependent on NOD2,
but the molecular mechanisms responsible for this phenomenon
are still not known. It is possible that TLR stimulation facilitates
the internalization of MDP, a process that is required for NOD2
activation under physiological conditions.
Although the biological roles of DAP and MDP in the activa-
tion of NOD1 and NOD2 have been described, the mechanism
underlying their internalization to the cytosol remains poorly
understood. Recent studies using an HEK293 transfection system
demonstrated that DAP and MDP reach the cytoplasm by endo-
cytosis, in a clathrin-dependent manner. Moreover, the cytosolic
internalization of the ligands was pH-dependent and occurred
prior to the acidification mediated by the vacuolar ATPase (Lee
et al., 2009). However, it remains to be determined whether this
process also occurs in primary cells such as macrophages, which
do not show robust activation in response to DAP or MDP alone
(Parant et al., 1995; Wolfert et al., 2002; Pauleau and Murray, 2003;
Kobayashi et al., 2005; Uehori et al., 2005; Kinsner et al., 2006;
Moreira et al., 2008a).
The current model of NLR signaling proposes that upon spe-
cific recognition of their ligands, the NBD domains oligomerize
and initiate the recruitment of interacting proteins leading to
the interaction of the CARD domain with the CARD-containing
kinase RIPK2 (also called RIP2/RICK) through a homotypic
CARD–CARD interaction (Kobayashi et al., 2002; Park et al.,
2007; Nembrini et al., 2009). This is accomplished via the recruit-
ment of the E3 ubiquitin ligase TRAF6 to RIPK2, followed by
TRAF6 autoubiquitination, polyubiquitination of RIPK2, and the
ubiquitination-dependent signaling and activation of the TAK1
complex. The activated TAK1 complex promotes the K63-type
polyubiquitination of IKK-β, culminating in the degradation of
the nuclear factor kappa-B (NF-κB) repressor IκB, the transloca-
tion of NF-κB to the nucleus, and the transcription of proinflam-
matory genes (Hasegawa et al., 2008; Figure 1). RIPK2 is critical for
the induction of NF-κB activation by NOD1 and NOD2, although
the molecular details concerning how the NOD/RIPK2 complex
stimulates NF-κB activation are only partially understood. In addi-
tion to NF-κB, NOD1, and NOD2 can activate the p38, ERK,
and JNK mitogen-activated protein kinases (MAPKs; Pauleau and
Murray, 2003; Kobayashi et al., 2005; Park et al., 2007). In addi-
tion, it was recently demonstrated that members of the inhibitor
of apoptosis protein (IAP) family of proteins, such as XIAP (Krieg
et al., 2009), cIAP1, and cIAP2 (Bertrand et al., 2009), interact
with RIPK2. Most important, it was demonstrated that cIAP1 and
cIAP2 function as E3 ubiquitin ligases responsible for the polyu-
biquitination of RIPK2, a process that is essential for the induction
of NF-κB activation by NOD1 and NOD2 (Bertrand et al., 2009;
Figure 1).
In addition to the bona fide interaction with RIPK2, NOD1,
and NOD2 have been reported to interact with other NLRs that are
important for caspase-1 activation. NOD2 was shown to specif-
ically and directly interact with NLRP1, NLRP3, and NLRP12,
whereas NOD1 interacts only with NLRP3 (Hsu et al., 2008;
Wagner et al., 2009).
NOD1 AND NOD2 EXPRESSION AND SIGNALING
REGULATION
NOD1 is widely expressed in many cell types, whereas NOD2
has been found in macrophages (Ogura et al., 2001), dendritic
cells (Tada et al., 2005), paneth cells (Ogura et al., 2003), ker-
atinocytes (Voss et al., 2006), epithelial intestinal cells (Hisamatsu
et al., 2003), lung epithelial cells (Uehara et al., 2007), oral epithe-
lial cells (Uehara et al., 2008), and osteoblasts (Marriott et al.,
2005). NOD1 and NOD2 expression can be induced by different
stimuli, such as live and heat-killed bacteria (Pudla et al., 2011);
TLR ligands, IFN-γ, and TNF-α (Rosenstiel et al., 2003; Kim et al.,
2007, 2008).
Little is known about how the NOD1 and NOD2 signal-
ing pathways are regulated and at which step(s) of the cascade
regulation occurs. One study showed that the ubiquitination
of RIPK2 induced by MDP appears to be regulated by A20, a
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FIGURE 1 | NOD1 and NOD2 signaling pathways and interaction
partners.The canonical adaptor protein required for the activation of the
signaling pathways downstream of NOD1 and NOD2 is the CARD-containing
kinase RIPK2, a protein that interacts with NOD1 or NOD2 via homotypic
CARD–CARD interactions leading to the activation of NF-κB and MAPKs.
NOD/RIPK2 signaling can be inhibited by caspase-12 and/or A20. NOD1 and
NOD2 proteins may also interact with the NLRP3 inflammasome, which leads
to caspase-1 activation and IL-18 and IL-1β production. Viral ssRNA triggers a
signaling pathway that is dependent on NOD2 and MAVS, leading to the
activation of IRF3 and the induction of type I interferon. NOD1 and NOD2
activate the autophagy machinery through their interactions with ATG16L1
protein. Abbreviations include: NOD1, nucleotide-binding oligomerization
domain 1; NOD2, nucleotide-binding oligomerization domain 2; RIPK2,
receptor-interacting serine/threonine-protein kinase 2; CARD, caspase
recruitment domain; JNK, c-Jun N-terminal kinases; TAK1, transforming
growth factor-beta-activated kinase 1 TAK1; cIAP, inhibitor of apoptosis
protein; NEMO, NF-κB essential modulator; IKK-γ, inhibitor of nuclear factor
kappa-B kinase-gamma; IKK, I-kappa-B kinase; Ub, ubiquitinated; A20,
ubiquitin-modified enzyme; ERK, extracellular-signal-regulated kinases; ASC,
apoptosis-associated speck-like protein containing a CARD; IL-1β,
interleukin-1; IL-18, interleukin-18; ssRNA, single-stranded RNA; MAVS,
mitochondria anti-virus signaling protein; IFR3, interferon regulatory factor 3;
Atg, autophagy-related gene; MAPK, mitogen-activated protein kinase; NF-κB,
nuclear factor κB. Specific Domains of NOD1 and NOD2 are indicated: NBD
or NACHT (green rectangle); LRR (hatched rectangle); CARD (purple
rectangle).
ubiquitin-modifying enzyme. A20-deficient cells exhibit ampli-
fied responses to MDP, including increased RIPK2 ubiquitylation,
prolonged NF-κB signaling, and increased production of proin-
flammatory cytokines. The same phenotype was observed in vivo
when A20-deficient mice were stimulated with MDP (Hitot-
sumatsu et al., 2008). Another study showed that caspase-12, an
enzyme that modulates caspase-1 activation, binds to RIPK2, dis-
placing TRAF6 from the signaling complex, a process that leads
to the inhibition of ubiquitin ligase activity and consequently the
blunting of NF-κB activation (LeBlanc et al., 2008).
Interestingly, several studies have shown that NOD1 and NOD2
bind/interact with different intracellular molecules that may posi-
tively or negatively regulate their signaling pathway. These studies
suggest the existence of a highly complex network of protein–
protein interactions underlying the biological functions of NOD1
and NOD2 (Table 1).
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Table 1 | Molecules reported to directly interact with NOD1 and/or NOD2.
Molecule NOD1 NOD2 Function/model Reference
RIPK2 + + Activation of NF-κB and MAPK/mice and human Inohara et al. (2000), Kobayashi et al. (2002)
and reviewed in (Inohara et al., 2002)
NLRP1 + Inflammasome signaling/mice and human* Hsu et al. (2008), Wagner et al. (2009)
NLPR3 + Inflammasome signaling/human* Wagner et al. (2009)
NLRP12 + Inflammasome signaling/human* Wagner et al. (2009)
Erbin + Negative regulator of NOD2 signaling/human* McDonald et al. (2005)
CENT-1β + + Negative regulator of NOD2 signaling/human* Yamamoto-Furusho et al. (2006)
Rac1GTPase + Negative regulator of NOD2 signaling/human* Eitel et al. (2008)
RIG-1 + Negative regulator of NOD2 signaling/human* Morosky et al. (2011)
JNK-binding
protein (JNKBP1)
+ Negative regulator of NOD2 signaling/mice and human* Lecat et al. (2012)
GRIM-19 + Positive regulator of NOD2 signaling/human* Barnich et al. (2005)
CARD9 + Positive regulator of NOD2 signaling/mice and human* Hsu et al. (2007)
Vimentin + Positive regulator of NOD2 signaling/human* Stevens et al. (2012)
BID + + Signaling for activation of ERK and NF-κB/mice and human* Yeretssian et al. (2011)
Atg16L1 + + Induction of autophagy/mice and human* Travassos et al. (2010)
Induction of autophagy/human* Cooney et al. (2010)
Regulation of autophagy/human* Homer et al. (2012)
*Phenotypes detected in human cells and/or in mammalian cells transfected with human molecules.
Positive regulators of NOD1 and NOD2 signaling have also
been described. A study showed that GRIM-19, a protein involved
in cell death, binds to NOD2 and is required for NF-κB activa-
tion (Barnich et al., 2005). Other molecules, such as the CARD-
containing adaptor protein 9 (CARD9), operate downstream of
NOD2 to trigger the RIPK2-independent activation of p38 and
JNK (Hsu et al., 2007; Figure 1).
The NOD1 and NOD2 proteins have been reported to interact
with the apoptotic pathway through additional mechanisms, aside
from the role of IAP proteins in the NOD1 and NOD2 signaling
pathway (Bertrand et al., 2009; Krieg et al., 2009). Yeretssian et al.
(2011) demonstrated that BID, a BLC2 family protein, interacts
directly with NOD1, NOD2, and the IκB kinase (IKK) complex
in a process that is important for NF-κB and ERK activation, sug-
gesting a non-apoptotic role for BID (Yeretssian et al., 2011). This
study used bone marrow-derived macrophages (BMDMs) from
Bid−/− mice, which failed to activate NF-κB and ERK and were
unable to secrete inflammatory cytokines upon stimulation with
NOD ligands. In addition, Bid−/− mice were unable to trigger
cytokine production in vivo after challenge with NOD ligands
(Yeretssian et al., 2011). In contrast, a study performed by Nach-
bur and colleagues demonstrated that Bid-deficient mice had the
same phenotype as wild-type mice upon stimulation with NOD
ligands. Moreover, the activation of NF-κB and ERK were simi-
lar in both Bid−/−and wild-type mice, suggesting that BID is not
essential for NOD signaling (Nachbur et al., 2012). It is possible
that differences in the gut microbiota associated with the animals
affect their responses to NOD ligands. Additional studies, includ-
ing co-housing experiments, will be required to clarify the role of
BID in NOD signaling and to determine whether NOD proteins
interfere with BID-dependent apoptosis.
Negative regulators of NOD signaling may reduce NOD1
or NOD2 signaling by inhibiting their interaction with other
molecules in the pathway. One example is ERBIN, an LRR-
containing protein that binds to NOD2, inhibiting MDP-induced
signaling (McDonald et al., 2005). NOD1 and NOD2 signaling
may also be inhibited by Centaurin β-1 (CENTβ1), a GTPase-
activating protein that is a member of the ADP-ribosylation
family and colocalizes with NOD1 and NOD2 in the cytoplasm
of intestinal epithelial cells. Over-expression of CENTβ1 inhib-
ited NOD1- and NOD2-dependent NF-κB signaling (Yamamoto-
Furusho et al., 2006). Rac1 GTPase and retinoic-acid induced
gene-1 (RIG-I) have also been shown to interact with NOD2
and inhibit its signaling (Eitel et al., 2008; Morosky et al.,
2011).
NOD1 AND NOD2 IN CHRONIC DISEASES
Studies have revealed that some individuals with familial Crohn’s
disease, a chronic inflammatory condition of the gut, have muta-
tions in the Card15 gene encoding NOD2 (Hugot et al., 2001;
Ogura et al., 2001), but not NOD1 (Zouali et al., 2003). The
most common Card15 mutation associated with Crohn’s disease
is an L100fs frameshift insertion at nucleotide 3020 (3020insC) in
the LRR region of NOD2 (Hugot et al., 2001). Although signifi-
cant, only a small percentage of Crohn’s disease patients harbor
this Card15 mutation (Hugot et al., 2001; Ogura et al., 2001;
Lesage et al., 2002). In addition, mutations in the NBD region
(R334W, R334Q, and L469F) have been associated with another
inflammatory disorder known as Blau syndrome (Miceli-Richard
et al., 2001). However, it is still poorly understood how polymor-
phisms in the NOD2 LRR (L100fs) or NBD (R334W, R334Q, and
L469F) domains contribute to Crohn’s disease and Blau syndrome,
respectively. Some current ideas about NOD2 polymorphisms in
Crohn’s disease patients were previously reviewed and discussed
elsewhere (Schroder and Tschopp, 2010). NOD2 polymorphisms
have also been associated with a variety of human inflammatory
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diseases, such as atopic eczema (Weidinger et al., 2005), arthri-
tis (Joosten et al., 2008; Vieira et al., 2012), atopic dermatitis
(Macaluso et al., 2007), sarcoidosis (Kanazawa et al., 2005), and
possibly asthma (Hysi et al., 2005; Duan et al., 2010), and endome-
trial (Ashton et al., 2010) or prostate cancer (Kang et al., 2012).
More recently, it was demonstrated that human NOD2 poly-
morphisms were also associated with increased susceptibility to
infectious diseases, such as leprosy (Zhang et al., 2009; Berrington
et al., 2010a), and tuberculosis (Austin et al., 2008; Azad et al.,
2012).
NOD1 AND NOD2 FUNCTIONS IN THE RESPONSE TO
BACTERIAL INFECTION
The initial studies regarding the functional properties of NOD1
and NOD2 as intracellular receptors for the recognition of pepti-
doglycan and live bacteria were performed using in vitro models.
These studies showed that NOD1 senses a substantial variety of
Gram-negative bacteria while NOD2 senses Gram-positive and
Gram-negative bacteria (Table 2).
The role of NOD1 and NOD2 in detecting specific micro-
bial products in vitro was further demonstrated in mutant mice
through the targeted deletion of these genes. Initial studies on
NOD2 function in mice were performed using Nod2 knockout
mice created through an insertion mutation in the first exon
encoding the first part of the second CARD domain (Pauleau
and Murray, 2003). Surprisingly, these mice did not show evi-
dent intestinal dysfunction, even though BMDMs obtained from
these mice did not respond to MDP stimulation, thus confirming
the loss-of-function of NOD2 (Pauleau and Murray, 2003). Later,
two other NOD2 transgenic mice were engineered: one with an
insertion causing a frameshift mutation in the final LRR domain,
corresponding to one of the most frequent mutation observed in
familial Crohn’s disease patients (Maeda et al., 2005), and another
with a loss-of-function insertion in the Card15 locus (Kobayashi
et al., 2005). As reported by Pauleau and colleagues, the transgenic
mice constructed by Maeda et al. and Kobayashi et al. show no
intestinal pathology under normal housing conditions (Pauleau
and Murray, 2003).
Table 2 | Functions of NOD1 and/or NOD2 in host responses to pathogenic microbes.
Microrganism Model/protein Reference
PROTOZOA
Toxoplasma gondii Mouse/NOD2 Shaw et al. (2009)
Trypanosoma cruzi Mouse/NOD1 Silva et al. (2010)
Plasmodium berghei ANKA Mouse/NOD1 and NOD2 Finney et al. (2009)
BACTERIA
Bacillus anthracis Mouse/NOD2 Hsu et al. (2008)
Mouse/NOD1 and NOD2 Loving et al. (2009)
Borrelia burgdorferi Human cells and mouse/NOD2 Oosting et al. (2010)
Burkholderia pseudomallei Human cell line and mouse/NOD2 Pudla et al. (2011)
Campylobacter jejuni Human cell line/NOD1 Zilbauer et al. (2007)
Chlamydophila pneumoniae Human cell line/NOD1 Opitz et al. (2005), Shimada et al. (2009)
Chlamydia trachomatis and Chlamydia muridarum Human cell line and mouse/NOD1 Welter-Stahl et al. (2006)
Clostridium difficile Mouse/NOD1 Hasegawa et al. (2011)
Citrobacter rodentium Mouse/NOD2 Kim et al. (2011b)
Escherichia coli entero-invasive Human cell line/NOD1 Kim et al. (2004)
Haemophilus influenzae Mouse/NOD1 Zola et al. (2008)
Helicobacter pylori Human cell line, mouse, and clinical study/NOD1 Watanabe et al. (2011)
Helicobacter hepaticus Mouse/NOD2 Biswas et al. (2010), Grubman et al. (2010)
Legionella pneumophila Human cell line and mouse/NOD1 and NOD2 Shin et al. (2008), Berrington et al. (2010b),
Frutuoso et al. (2010)
Listeria monocytogenes Human cell line/NOD1 Opitz et al. (2006)
Mycobacterium tuberculosis Human cells/NOD2 Brooks et al. (2011)
Mouse/NOD2 Divangahi et al. (2008)
Porphyromonas gingivalis Human cells/NOD1 and NOD2 Uehara et al. (2008)
Propionibacterium acne Human cells and clinical study/NOD1 and NOD2 Tanabe et al. (2006)
Pseudomonas aeruginosa Human cell line and murine fibroblast/NOD1 Travassos et al. (2005)
Salmonella enterica Mouse/NOD1 Le Bourhis et al. (2009)
Mouse/NOD1 and NOD2 Geddes et al. (2010), Keestra et al. (2011)
Shigella flexneri Human cell line/NOD1 Girardin et al. (2001)
Streptococcus pneumoniae Human cell line/NOD 2 Opitz et al. (2004)
VIRUS
Respiratory syncytial virus (RSV) Mice/NOD2 Sabbah et al. (2009)
Murine norovirus-1 Mouse/NOD1 and NOD2 Kim et al. (2011a)
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Although Nod2−/− mice did not show any inflammatory phe-
notype in the gut, several reports demonstrated their increased
susceptibility to bacterial infections. For Listeria monocytogenes
infection, NOD2 was shown to be important for restricting bac-
terial multiplication because Nod2−/− mice orally infected with L.
monocytogenes showed decreased production of β-defensins and
an increased bacterial burden (Kobayashi et al., 2005; Kim et al.,
2008).
Similar features were observed in Nod1−/− mice infected with
Helicobacter pylori; NOD1 was shown to be important for the
recognition of peptidoglycan translocated from the bacterial cell
to the host cell cytoplasm through the cag type IV secretion sys-
tem. This feature accounts for NOD1-dependent responses that
generate resistance against infection (Viala et al., 2004; Boughan
et al., 2006).
In a pulmonary model of infection with Chlamydophila pneu-
moniae, NOD2, and RIPK2 were found to be critical for host
responses; Nod2- and Ripk2-deficient mice infected with C.
pneumoniae exhibited impaired production of nitric oxide and
chemokine (C-X-C motif) ligand 1 production and delayed neu-
trophil recruitment to the lungs (Shimada et al., 2009). Defective
recruitment of neutrophils to the intestines was also observed in
Nod1−/− mice infected with Clostridium difficile, possibly due
to the impairment of CXCL1 production. The increased mor-
tality of the Nod1−/− mice was accompanied by impaired C.
difficile clearance and increased bacterial translocation from the
intestines to other organs, a process that resulted in elevated levels
of microbiota-derived endotoxin and IL-1β in the sera of Nod1−/−
mice (Hasegawa et al., 2011).
Some authors have reported that both NOD1 and NOD2 func-
tion in a synergistic fashion to tune the appropriate responses
to certain pathogens. For example, NOD1 and NOD2 double-
deficient mice showed a significant reduction in the production
of inflammatory cytokines and an increase in the bacterial colo-
nization of the mucosal tissue in a Salmonella model of colitis.
These phenotypes were not observed in Nod1−/− or Nod2−/−
single knockouts (Geddes et al., 2010). The same group further
demonstrated that NOD1 and NOD2 were crucial for the induc-
tion of mucosal Th17 responses during the early stages of infection
with Citrobacter rodentium and S. enterica Typhimurium (Geddes
et al., 2011). Of note, this response was dependent on the intesti-
nal microbiota, a concept that may flourish in this field within the
next few years.
Cooperation between NOD1 and NOD2 was also reported in
a murine model of Bacillus anthracis. Mice deficient for both
NOD1 and NOD2 were more susceptible to lethal challenge with
B. anthracis and produced lower levels of proinflammatory mole-
cules when compared with single knockouts (Loving et al., 2009).
A similar phenomenon was observed after pulmonary infection
of mice with Legionella pneumophila, an intracellular bacterial
pathogen that has been used as an excellent model for investi-
gating bacterial recognition by innate immune receptors (Vance,
2010; Massis and Zamboni, 2011). NOD1 or NOD2 single knock-
out mice effectively restricted the replication of L. pneumophila
in the lungs; in contrast, RIPK2-deficient mice were less efficient
at clearing pulmonary bacteria (Frutuoso et al., 2010). Additional
investigation using Ripk2−/−mice indicated that the NOD/RIPK2
pathway cooperates with TLR signaling to restrict bacterial
growth in mouse lungs; RIPK2/MyD88 double-deficient mice
were significantly more susceptible to L. pneumophila infection
compared with MyD88 single knockout mice (Archer et al., 2010).
Another study performed with L. pneumophila indicated
that NOD1 and NOD2 drive distinct inflammatory responses
(Berrington et al., 2010b). Nod1−/− mice showed impaired bac-
terial clearance and neutrophil recruitment to the alveolar space
and decreased production of proinflammatory cytokines when
compared with wild-type mice. In contrast, increased levels of
lung neutrophils and proinflammatory cytokine production were
observed in Nod2−/− infected mice. However, at later stages of
infection, both Nod1−/− and Nod2−/− mice produced signifi-
cantly increased levels of proinflammatory cytokines in the lungs
(Berrington et al., 2010b). Collectively, these studies indicate that
although NOD1/NOD2/RIPK2 signaling is not critical for host
resistance against Legionella pneumophila, both NOD1 and NOD2
participate in the recognition of these bacteria in vivo (Archer
et al., 2010; Berrington et al., 2010b; Frutuoso et al., 2010).
Regardless of the roles of NOD1 and NOD2 in the immune
response to certain microbes, for some bacterial pathogens, such
as Coxiella burnetii and Brucella abortus, NOD1 and NOD2 play
no role in restricting bacterial replication in murine models of
infection (Benoit et al., 2009; Oliveira et al., 2012). This may also
be the case for other pathogenic bacteria that bypass and/or are
refractory to NOD1- and NOD2-mediated immunity.
NOD1 AND NOD2 IN RESPONSE TO
NON-PEPTIDOGLYCAN-CONTAINING PATHOGENS
As reviewed so far, the role of NOD1 and NOD2 in sensing bacter-
ial products has been intensively investigated. Moreover, the use of
Nod1−/− and Nod2−/− mice supported the key role of these mol-
ecules in restricting bacterial infection (Table 2). However, recent
reports indicate that NOD1 and NOD2 also play a role in host
responses against protozoan parasite infections.
Nod2−/− mice failed to clear Toxoplasma gondii infection and
succumbed at similar rates to MyD88−/− mice. NOD2 was shown
to be involved in a T cell-intrinsic function rather than being active
in macrophages and DCs (Shaw et al., 2009). Moreover, Nod2−/−
mice failed to trigger IFN-γ production and to induce the dif-
ferentiation of Th1 lymphocytes (Shaw et al., 2009). However,
these observations were not corroborated by studies performed
by three independent groups (Caetano et al., 2011). The reason
for these discrepancies maybe related to variations in the bacterial
microbiota present in the guts of the NOD2-deficient mice. Fur-
ther studies, including those involving co-housing and the use of
germ-free mice, will be required to address this issue. The T cell-
intrinsic defect in Nod2−/− mice could explain why these mice are
partially defective at generating antigen-specific antibodies even in
the absence of NOD2 ligands (Moreira et al., 2008a). Nonetheless,
the role of NOD2 signaling in CD4+ T cells requires additional
investigation.
Studies performed with other intracellular protozoan parasites,
such as Plasmodium berghei ANKA and Trypanosoma cruzi, indi-
cated that NOD2 was not required for host protection against
these parasites (Finney et al., 2009; Silva et al., 2010). In contrast,
NOD1 was associated with host resistance against T. cruzi infection
Frontiers in Immunology | Inflammation November 2012 | Volume 3 | Article 328 | 6
Moreira and Zamboni NOD signaling in infection and inflammation
in vivo (Silva et al., 2010). BMDMs from Nod1−/− mice showed
impaired induction of NF-κB-dependent products in response to
infection and failed to restrict T. cruzi infection in the presence
of IFN-γ. Despite normal cytokine levels in the sera, Nod1−/−
mice were highly susceptible to T. cruzi infection in a similar
manner to MyD88−/− and NO synthase 2 (iNOS)-deficient mice.
This study indicated that NOD1-dependent responses accounted
for host resistance to T. cruzi infection via cytokine-independent
mechanisms (Silva et al., 2010).
Interestingly, in addition to the detection of bacteria and pro-
tozoa, NOD2 has an important role in virus recognition during
experimental infection (Sabbah et al., 2009). NOD2, but not
NOD1, was shown to facilitate IRF3 activation and the produc-
tion of type I IFN in response to single-stranded RNA (ssRNA)
or infection with respiratory syncytial virus (RSV; Sabbah et al.,
2009). The authors showed that ssRNA and RSV, which does not
contain peptidoglycan, activated NOD2 through a mechanism
that was dependent on MAVS (mitochondrial antiviral signaling
protein) and led to the activation of IRF3. Another recent study
demonstrated that bacteria-infected mice co-stimulated with poly
I:C or IFN-γ or co-infected with murine norovirus-1 dramati-
cally augmented NOD1 and NOD2 signaling and expression and
the production of proinflammatory cytokines. This response was
attenuated in NOD1/NOD2 double knockout or RIPK2-deficient
mice. The crosstalk between NOD1/NOD2 and type I IFN sig-
naling may somehow facilitate bacterial recognition; however, it
also induces harmful effects in the virally infected host (Kim et al.,
2011a). These data contribute to our understanding of the lethal
effects of host co-infection by two pathogens that are not normally
lethal in singly infected hosts (Jamieson et al., 2010).
Although these initial reports indicated that NOD1 and NOD2
might be important in responses to non-bacterial pathogens, fur-
ther studies will be required to address the roles of NOD1 and
NOD2 in the recognition of pathogens that lack peptidoglycan
moieties. In this context, it is important to determine whether
NOD1 and NOD2 act as bonafide receptors for these pathogens
or whether they take part in signaling pathways triggered by other
innate immune molecules.
NOD1 AND NOD2 IN AUTOPHAGY INDUCTION
Recent reports have shown that NOD1 and NOD2 are associ-
ated with the induction of macroautophagy, a highly conserved
degradation system in which specific cell components, including
damaged organelles or proteins, are engulfed into a double-layered
membrane structure for further degradation (reviewed in Lu and
Walsh, 2012). Autophagy is also considered an immunologically
regulated process and represents an innate defense mechanism
that can control the replication of intracellular pathogens, includ-
ing Mycobacterium tuberculosis and others (Gutierrez et al., 2004;
Ogawa et al., 2011). Both NOD1 and NOD2 were shown to
recruit ATG16L1 to the plasma membrane at the site of bacterial
entrance to initiate autophagy (Travassos et al., 2010). In addi-
tion, NOD2 agonists induced autophagy in DCs in a RIPK2-,
ATG5-, and ATG7-dependent manner (Cooney et al., 2010). In
fact, polymorphisms in the ATG16L1 gene are known to be a risk
factor for the development of Crohn’s disease in humans (Naser
et al., 2012). NOD-dependent autophagy induction occurs after
cell stimulation with peptidoglycan or live Shigella flexneri and
is independent of RIPK2 (Travassos et al., 2010). Nonetheless,
additional studies have reported that RIPK2 is necessary for the
NOD2-mediated induction of autophagy (Cooney et al., 2010;
Anand et al., 2011; Homer et al., 2012). The studies performed
by Travassos et al. and Cooney et al. were the first to suggest
that NOD1 and NOD2 function as a molecular scaffold for the
autophagy machinery and may thereby act as nucleation sites for
autophagy initiation (Cooney et al., 2010; Travassos et al., 2010).
More recently, different groups have reported a role for NOD1
and/or NOD2 in the induction of autophagy in response to several
pathogens including S. Typhimurium, M. tuberculosis, adherent-
invasive E. coli, and L. monocytogenes (Anand et al., 2011; Homer
et al., 2012; Juarez et al., 2012; Lapaquette et al., 2012).
NOD1 AND NOD2 IN ADAPTIVE IMMUNITY
Although NOD1 and NOD2 are associated with innate immune
responses, several reports have demonstrated their involvement in
the induction of adaptive immune responses. In fact, for certain
infections, impairment of NOD1 and NOD2 function interferes
with both innate and adaptive immune responses (Divangahi et al.,
2008; Shaw et al., 2009).
NOD2 stimulation with MDP triggers an antigen-specific
immune response with a Th2-type polarization profile, charac-
terized by the production of IL-4 and IL-5 by T cells and IgG1
antibody responses (Magalhaes et al., 2008). Other studies have
suggested that NOD1 is important for T cell priming and anti-
body production. NOD1 stimulation with its agonist alone was
sufficient to drive a Th2 antigen-specific immune polarization.
NOD1-deficient mice showed a reduced frequency of IFN-γ −
producingCD4+ and CD8+ T cells and decreased antibody pro-
duction, suggesting that NOD1 was required for optimal T and B
cell responses (Fritz et al., 2007); a similar effect was also described
for NOD2 (Shaw et al., 2009).
NOD2 was also found to be critical for the induction of both
Th1- and Th2-type responses following co-stimulation with TLR
agonists (Magalhaes et al., 2008). The lack of NOD2-dependent
Th2 differentiation in a subset of Crohn’s disease patients might
explain how the Th1-mediated inflammation at the intestinal
mucosa contributes to the pathogenesis of the disease (Magal-
haes et al., 2008). However, the use of MDP as an adjuvant is
controversial because MDP alone is a weak adjuvant compared
with TLR agonists (Magalhaes et al., 2008). Therefore, MDP may
be inefficient at triggering adequate adaptive immune responses,
as previously reported (Moreira et al., 2008a).
REGULATION OF IMMUNE RESPONSES BY NOD1 AND NOD2
It is possible that NOD2 has a regulatory function for innate
immune responses, acting as a transducer modifier as previously
suggested (Murray, 2005). Watanabe and colleagues demonstrated
that mixed splenocyte cultures from Nod2−/− mice produced
high levels of IL-12 upon stimulation with PGN, and a simi-
lar phenotype was observed in vivo when Nod2−/− mice were
injected with PGN (Watanabe et al., 2004). Intact NOD2 signal-
ing inhibited the TLR2-driven activation of NF-κB, particularly
the NF-κB subunit c-Rel. Moreover, NOD2 deficiency or the
presence of a Crohn’s disease-like Card15 mutation increased
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the TLR2-mediated activation of NF-κBc-Rel and Th1 responses
(Watanabe et al., 2004). Thus, Card15 mutations may lead to
disease by causing excessive Th1 responses. This finding was cor-
roborated by the fact that BMDMs from Nod2−/− mice produced
less IL-10 upon stimulation with PGN purified from Streptococcus
pneumoniae, suggesting that NOD2 may have a regulatory effect
on IL-10 production (Moreira et al., 2008b). The reduction of
IL-10 production would lead to increased production of IL-12,
thereby contributing to the excessive inflammation observed in
Crohn’s disease patients (Moreira et al., 2008b). In fact, it was
recently demonstrated that the Crohn’s-disease-associated NOD2
mutation suppresses human IL-10 transcription by inhibiting the
activity of the nuclear ribonucleoprotein hnRNP-A1 (Noguchi
et al., 2009). The NOD2 3020insC mutation blocks p38 phos-
phorylation of hnRNP-A1, which impairs hnRNP-A1 binding
to the IL-10 locus in peripheral blood mononuclear cells from
Crohn’s disease patients (Noguchi et al., 2009). These findings are
consistent with the previous suggestion that NOD2 may inter-
fere with the production of IL-10 (Moreira et al., 2008b), a
cytokine that is important for the regulation of inflammatory
processes.
In another mouse model, a NOD2 mutation potentiated NF-
κB activity and IL-1β processing, suggesting that NOD2 may
act as a positive regulator of NF-κB activation and IL-1β secre-
tion, thereby increasing the intestinal inflammation observed in
Crohn’s disease patients (Maeda et al., 2005). The mechanism
by which mutations in the Card15 gene influence the chronic
inflammation status observed with Crohn’s disease is still poorly
understood. Because signaling via mutated NOD2 proteins leads
to defective activation of NF-κB, one hypothesis is that muta-
tions causing deficient NF-κB-dependent Th1 responses increase
susceptibility to gut infections. This idea is supported by recent
findings showing that wild-type NOD2, but not the mutant vari-
ants found in humans, can mediate autophagy, thereby allowing
the clearance of bacterial pathogens that reach the host cell
cytoplasm.
CONCLUDING REMARKS
The NOD1 and NOD2 proteins play a remarkable role in host
immune responses. Despite their undisputed importance for host
defense, the specific mechanisms underlying their functions are yet
to be determined. Although it is clear that these molecules are able
to sense bacterial cell wall components and pathogens, their unique
role as intracellular “receptors” is still a matter of debate. Although
direct binding of MDP to NOD2 has recently been demonstrated
(Grimes et al., 2012), alternative functions for the NODs, such
as regulation of signal transduction systems have been proposed
(Murray, 2005; Strober et al., 2006), thus corroborating the idea
that NOD1 and NOD2 are multifaceted proteins. As mentioned
in this review, NOD2 may interfere with IL-10 production and
act as a regulatory molecule rather than an inflammatory inducer.
The roles of NOD1 and NOD2 in the induction and resolution
of inflammatory processes are largely unknown. A more compre-
hensive understanding of the functions of NOD1 and NOD2 in
mammalian immunity may allow the use of new pharmacological
interventions to either boost or reduce inflammatory responses
against pathogenic microbes.
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